Performance Characteristics of HIV-1 Culture and HIV-1 DNA and RNA Amplification Assays for Early Diagnosis of Perinatal HIV-1 Infection
- 1 December 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 34 (5) , 512-519
- https://doi.org/10.1097/00126334-200312150-00011
Abstract
A plasma HIV-1 RNA amplification assay (RNA assay), a quantitative peripheral blood mononuclear cell (PBMC) microculture (culture), and a PBMC HIV-1 DNA amplification assay (DNA assay) were compared for diagnosis of HIV-1 infection in infants receiving zidovudine in Pediatric AIDS Clinical Trials Group protocol 185; assays were performed for all 24 infected and 100 uninfected infants. HIV-1 infection was defined as ≥2 positive cultures or positive antibody to HIV-1 at ≥18 months. Cultures were performed at birth and 6 and 24 weeks of age; DNA and RNA assays were performed on cryopreserved specimens. The sensitivity of culture and DNA and RNA assays at birth was 20.8%, 10.5%, and 26.7%, respectively. At older ages, sensitivity typically exceeded 80%, remaining highest for the RNA assay (>85%). Assay specificity was >99%. Positive predictive values exceeded 93% for each assay at each age; negative predictive values were highest (>90%) for the RNA assay. At birth (P < 0.005) and age 6 weeks (P < 0.001), a significantly larger proportion of infected infants were identified by means of the RNA assay than by the other assays. The diagnostic performance of the RNA assay matched or exceeded that of culture and the DNA assay. Given that RNA assays require less blood volume and yield rapid results, our study adds to existing data suggesting that RNA assays may be used for early diagnosis of HIV-1 infection in infants.Keywords
This publication has 25 references indexed in Scilit:
- Efficacy of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin for Reducing Perinatal HIV Transmission from HIV‐Infected Women with Advanced Disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185The Journal of Infectious Diseases, 1999
- Evaluation of HIV1 infection status by HIV1 PCR and culture methodologies in a small cohort of intravenous drug usersResearch in Virology, 1997
- The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmissionAIDS, 1995
- Clinical Evaluation of Branched DNA Signal Amplification for Quantifying HIV Type 1 in Human PlasmaAIDS Research and Human Retroviruses, 1995
- Human Immunodeficiency Virus Type 1 Quantitative Cell Microculture as a Measure of Antiviral Efficacy in a Multicenter Clinical TrialThe Journal of Infectious Diseases, 1995
- The Use of Viral Culture and p24 Antigen Testing to Diagnose Human Immunodeficiency Virus Infection in NeonatesNew England Journal of Medicine, 1992
- Rapid and Quantitative Detection of Enzymatically Amplified HIV-1 DNA Using Chemiluminescent Oligonucleotide ProbesAIDS Research and Human Retroviruses, 1990
- A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virusThe Journal of Pediatrics, 1990
- The Use of Non-Radioactive Oligonucleotide Probes to Analyze Enzymatically Amplified DNA for Prenatal Diagnosis and Forensic HLA TypingNature Biotechnology, 1988
- DNA Amplification for Direct Detection of HIV-1 in DNA of Peripheral Blood Mononuclear CellsScience, 1988